NewsBenzinga캐슬 바이오사이언스, 2026회계연도 매출 가이던스 3억6,500만~3억7,500만 달러에서 3억8,500만~3억9,500만 달러로 상향 조정 (시장 예상치 3억7,375만 달러) 캐슬 바이오사이언스, 2026회계연도 매출 가이던스 3억6,500만~3억7,500만 달러에서 3억8,500만~3억9,500만 달러로 상향 조정 (시장 예상치 3억7,375만 달러) Benzinga 2026.11.05 21:18 (GMT+0) Open on Benzinga Other news OpenAI CEO Sam Altman says it’s ‘hard to imagine the AI industry without Jensen’ Nvidia’s Jensen Huang Scandal Just Got More Expensive Billionaire Brad Gerstner Is Betting $5 Billion on the Anthropic IPO. The Smart Money Is Shrugging Off the AI Panic. Sony’s updated turntable is an easy entry into the world of vinyl As Tesla Plans to Roll Out the Cybercab for Individual Use, TSLA Stock Is a Tough Nut to Crack How the Anthropic IPO stacks up against SpaceX
Billionaire Brad Gerstner Is Betting $5 Billion on the Anthropic IPO. The Smart Money Is Shrugging Off the AI Panic.